INFORMAZIONI SU QUESTO EPISODIO
Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
1
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di What Pharma Needs Next.
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Veeva Systems, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.